Goehring & Rozencwajg Associates’s Hudbay HBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-824,951
Closed -$16.4M 45
2025
Q4
$16.4M Buy
824,951
+51,387
+7% +$869K 1.62% 20
2025
Q3
$11.7M Sell
773,564
-4,501
-0.6% -$51.5K 1.41% 25
2025
Q2
$8.26M Sell
778,065
-19,583
-2% -$163K 1.26% 28
2025
Q1
$6.63M Buy
797,648
+17,361
+2% +$141K 1.2% 31
2024
Q4
$6.14M Sell
780,287
-33,063
-4% -$296K 1.26% 31
2024
Q3
$7.48M Buy
813,350
+45,781
+6% +$369K 1.52% 28
2024
Q2
$6.94M Buy
767,569
+109,899
+17% +$954K 1.38% 31
2024
Q1
$4.6M Buy
657,670
+45,701
+7% +$266K 1% 37
2023
Q4
$3.37M Buy
611,969
+19,805
+3% +$92.8K 0.82% 40
2023
Q3
$2.89M Buy
592,164
+18,427
+3% +$93.4K 0.71% 41
2023
Q2
$2.75M Buy
+573,737
New +$2.8M 0.79% 39

Other funds holding HBM

Goehring & Rozencwajg Associates's HBM Position: Q1 2026 in Review

Goehring & Rozencwajg Associates sold out of Hudbay (HBM) in Q1 2026, closing a stake of 824,951 shares — an estimated $16.4M sold.

Goehring & Rozencwajg Associates first reported a position in HBM in Q2 2023 and held it in 11 quarters. The position peaked at $16.4M in Q4 2025. 295 funds tracked by Wall St. Rank hold HBM as of Q1 2026.

  • Goehring & Rozencwajg Associates reported no remaining Hudbay position as of Q1 2026 after selling out during the quarter.
  • Goehring & Rozencwajg Associates sold 824,951 Hudbay shares in Q1 2026, an estimated $16.4M.
  • Goehring & Rozencwajg Associates first reported a position in Hudbay in Q2 2023 and held it in 11 quarters.
  • Goehring & Rozencwajg Associates's Hudbay position peaked at $16.4M in Q4 2025.
  • 295 funds tracked by Wall St. Rank held Hudbay as of Q1 2026.

Based on Goehring & Rozencwajg Associates's 13F filing for Q1 2026, filed 5 May 2026.